Gilead Sciences Customer Service

User Reviews, Ratings and Comments

Gilead Sciences must receive 5 more comments in order to receive a customer service rating.
Add your comments and ratings for Gilead Sciences customer service

NEGATIVE Comments

POSITIVE Comments

Issue Resolution

Reachability

Cancellation

Friendliness

Product Knowledge

There are currently not enough comments for Gilead Sciences to qualify for a rating. Listings must have at least 5 comments before a rating will be calculated.

  • Gilead Sciences

    Customer Service Scoreboard

    • 0.00 Overall Rating
      (out of 200 possible)
    • 0 negative comments (0.00%)
    • 0 positive comments (0.00%)
    • 0 employee comments
    • Attribute Ratings
      (out of 10 possible)
    • 0.0 Issue Resolution
    • 0.0 Reachability
    • 0.0 Cancellation
    • 0.0 Friendliness
    • 0.0 Product Knowledge

There are currently 0 Negative Comments for Gilead Sciences.

Be the first to submit a negative comment
There are currently 0 Positive Comments for Gilead Sciences.

Be the first to submit a positive comment
There are currently 0 Employee Comments for Gilead Sciences.

Be the first to submit a comment from an Employee

Awards

We are proud to recognize the companies providing the best customer service each year within their industry.

Comparisons

Check out these popular comparisons of Gilead Sciences customer service versus other companies:

Gilead Sciences vs. AbbVie
Gilead Sciences vs. Amgen
Gilead Sciences vs. Merck
Gilead Sciences vs. Pfizer
Company Replies

Authorized representatives of Gilead Sciences can sign up to reply to any of the comments found on this page.

Sign Up | Sign In

Contact Information
Customer Service
800-445-3235

Gilead Sciences customer service phone number including steps to reach representatives, hours of operation, customer support links and more from ContactHelp.com.
Corporate Office

Locate the Gilead Sciences corporate office headquarters phone number, address and more at CorporateOfficeOwl.com.

Company News
Gilead Sciences to Acquire Cell Design Labs
EMERYVILLE, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Cell Design Labs, Inc., a privately-held biotechnology company developing disruptive CAR-T and T cell receptor (TCR) therapies, announced today that Gilead Sciences (Nasdaq:GILD) has agreed to ...
Changes in Signals Identified: Brocade Communications Systems, Inc. (BRCD), Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD)'s latest quote $73.27 $0.07 -0.23% will find technical support in $72.83 a share and a breakdown below this region would be a significantly bearish signal for Gilead Sciences, Inc. traders. Any way you dice it, a dip ...
Gilead Sciences Breaks Out
Gilead Sciences (GILD - Get Report) is up sharply Wednesday but investors should not be too surprised. We said in recent update , "GILD only turned positive in late June, so we are not far off the lows, with plenty of room on the upside. Aggressive ...